Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04772989
Title A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arcus Biosciences, Inc.

Advanced Solid Tumor

cervical cancer

diffuse large B-cell lymphoma

non-Hodgkin lymphoma

multiple myeloma

gastroesophageal junction adenocarcinoma

esophageal cancer


stomach cancer

lung non-small cell carcinoma


AB308 + Zimberelimab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.